Bone Biologics (BBLG) Other Non-Current Liabilities (2016 - 2025)
Bone Biologics (BBLG) reported Other Non-Current Liabilities of $703.0 for Q4 2025, down 84.95% year-over-year from $4670.0 in Q4 2024, and down 41.47% quarter-over-quarter from $1201.0 in Q3 2025.
Bone Biologics (BBLG) Other Non-Current Liabilities (2016 - 2025) Analysis & Trends
Bone Biologics (BBLG) has 5 years of Other Non-Current Liabilities data on file, last reported at $703.0 in Q4 2025.
- Other Non-Current Liabilities for Q4 2025 came in at $703.0, down 84.95% year-over-year; the trailing twelve-month figure through Dec 2025 was $703.0 (down 84.95% YoY), and the FY2025 annual result was $703.0, down 84.95% from the prior year.
- Other Non-Current Liabilities slipped to $703.0 in Q4 2025 per BBLG's latest filing, from $1201.0 in the prior quarter.
- Over five years, Other Non-Current Liabilities peaked at $1.7 million in Q1 2023 and troughed at $703.0 in Q4 2025.
- A 4-year average of $294236.8 and a median of $17629.0 in 2024 frame the typical range for Other Non-Current Liabilities.
- The sharpest annual moves came in 2024 and 2025: Other Non-Current Liabilities tumbled 98.94% in 2024, then plunged 68.48% in 2025.
- A 4-year view of Other Non-Current Liabilities shows it stood at $1.7 million in 2022, then plunged by 96.64% to $55751.0 in 2023, then plunged by 91.62% to $4670.0 in 2024, then slumped by 84.95% to $703.0 in 2025.
- Business Quant data shows BBLG's Other Non-Current Liabilities at $703.0 in Q4 2025, $1201.0 in Q3 2025, and $2413.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - |
| 10 | Bone Biologics | 1.47 Mn | 1.47 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 703.00 |
| Sep 30, 2025 | 1,201.00 |
| Jun 30, 2025 | 2,413.00 |
| Mar 31, 2025 | 3,315.00 |
| Dec 31, 2024 | 4,670.00 |
| Sep 30, 2024 | 17,629.00 |
| Jun 30, 2024 | 7,655.00 |
| Mar 31, 2024 | 18,440.00 |
| Dec 31, 2023 | 55,751.00 |
| Sep 30, 2023 | 80,514.00 |
| Jun 30, 2023 | 241,160.00 |
| Mar 31, 2023 | 1.73 Mn |
| Dec 31, 2022 | 1.66 Mn |
| Jun 30, 2016 | 37,500.00 |
| Mar 31, 2016 | 115,000.00 |